Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns-Reference-Cited by-同舟云学术

Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns

Published:2020-08-02 Issue:8 Volume:19 Page:691-698
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Zellweger Raphaël M.¹,Wartel T. Anh¹,Marks Florian¹^ORCID,Song Manki²,Kim Jerome H.¹^ORCID

Affiliation:

1. Epidemiology, Public Health, Impact & Clinical Development Unit, International Vaccine Institute, Seoul, Republic of Korea

2. Science Unit, International Vaccine Institute, Seoul, Republic of Korea

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2020.1800463

Reference67 articles.

1. WHO. Annual review of diseases prioritized under the Research and Development Blueprint. 2018.

2. JHU. Covid-19 Global Cases by the Center for Systems Science and Engineering at JHU. [cited 2020 Jun 6]. Available from: https://coronavirus.jhu.edu/map.html

3. New Vaccine Technologies to Combat Outbreak Situations

4. WHO. DRAFT landscape of COVID-19 candidate vaccines – 20 March 2020. 2020.

5. LSHTM. COVID-19 vaccine development pipeline. [cited 2020 Jun 6]. Available from: https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus;2023-10-27

2. COVID‐19 in Chihuahua, Mexico: Assessing its spatial behaviour through the inverse distance weighted interpolation technique;Canadian Geographies / Géographies canadiennes;2023-05-23

3. Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach;Journal of Infection and Public Health;2022-11

4. Injectable Slow-Release Hydrogel Formulation of a Plant Virus-Based COVID-19 Vaccine Candidate;Biomacromolecules;2022-03-28

5. Non-clinical immunogenicity, biodistribution and toxicology evaluation of a chimpanzee adenovirus-based COVID-19 vaccine in rat and rhesus macaque;Archives of Toxicology;2022-02-28